267 related articles for article (PubMed ID: 21821913)
1. IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe-/- mice.
Wang J; Cheng X; Xiang MX; Alanne-Kinnunen M; Wang JA; Chen H; He A; Sun X; Lin Y; Tang TT; Tu X; Sjöberg S; Sukhova GK; Liao YH; Conrad DH; Yu L; Kawakami T; Kovanen PT; Libby P; Shi GP
J Clin Invest; 2011 Sep; 121(9):3564-77. PubMed ID: 21821913
[TBL] [Abstract][Full Text] [Related]
2. Reduced Nhe1 (Na
Liu CL; Liu X; Wang Y; Deng Z; Liu T; Sukhova GK; Wojtkiewicz GR; Tang R; Zhang JY; Achilefu S; Nahrendorf M; Libby P; Wang X; Shi GP
Hypertension; 2020 Jul; 76(1):87-100. PubMed ID: 32475310
[TBL] [Abstract][Full Text] [Related]
3. Na
Liu CL; Zhang X; Liu J; Wang Y; Sukhova GK; Wojtkiewicz GR; Liu T; Tang R; Achilefu S; Nahrendorf M; Libby P; Guo J; Zhang JY; Shi GP
Nat Commun; 2019 Sep; 10(1):3978. PubMed ID: 31484936
[TBL] [Abstract][Full Text] [Related]
4. IgE Contributes to Atherosclerosis and Obesity by Affecting Macrophage Polarization, Macrophage Protein Network, and Foam Cell Formation.
Zhang X; Li J; Luo S; Wang M; Huang Q; Deng Z; de Febbo C; Daoui A; Liew PX; Sukhova GK; Metso J; Jauhiainen M; Shi GP; Guo J
Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):597-610. PubMed ID: 31996021
[TBL] [Abstract][Full Text] [Related]
5. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.
Doddapattar P; Gandhi C; Prakash P; Dhanesha N; Grumbach IM; Dailey ME; Lentz SR; Chauhan AK
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2391-400. PubMed ID: 26427793
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine-1-phosphate receptor-2 deficiency leads to inhibition of macrophage proinflammatory activities and atherosclerosis in apoE-deficient mice.
Wang F; Okamoto Y; Inoki I; Yoshioka K; Du W; Qi X; Takuwa N; Gonda K; Yamamoto Y; Ohkawa R; Nishiuchi T; Sugimoto N; Yatomi Y; Mitsumori K; Asano M; Kinoshita M; Takuwa Y
J Clin Invest; 2010 Nov; 120(11):3979-95. PubMed ID: 20978351
[TBL] [Abstract][Full Text] [Related]
7. The role of immunoglobulin E and mast cells in hypertension.
Ge W; Guo X; Song X; Pang J; Zou X; Liu Y; Niu Y; Li Z; Zhao H; Gao R; Wang J
Cardiovasc Res; 2022 Nov; 118(14):2985-2999. PubMed ID: 35048969
[TBL] [Abstract][Full Text] [Related]
8. TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice.
Lu Z; Zhang X; Li Y; Jin J; Huang Y
J Endocrinol; 2013 Jan; 216(1):61-71. PubMed ID: 23060524
[TBL] [Abstract][Full Text] [Related]
9. Genetic Evidence Supports a Major Role for Akt1 in VSMCs During Atherogenesis.
Rotllan N; Wanschel AC; Fernández-Hernando A; Salerno AG; Offermanns S; Sessa WC; Fernández-Hernando C
Circ Res; 2015 May; 116(11):1744-52. PubMed ID: 25868464
[TBL] [Abstract][Full Text] [Related]
10. Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4.
Montecucco F; Braunersreuther V; Burger F; Lenglet S; Pelli G; Carbone F; Fraga-Silva R; Stergiopulos N; Monaco C; Mueller C; Pagano S; Dallegri F; Mach F; Vuilleumier N
Thromb Haemost; 2015 Aug; 114(2):410-22. PubMed ID: 25879306
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 7 stimulation by imiquimod induces macrophage autophagy and inflammation in atherosclerotic plaques.
De Meyer I; Martinet W; Schrijvers DM; Timmermans JP; Bult H; De Meyer GR
Basic Res Cardiol; 2012 May; 107(3):269. PubMed ID: 22543675
[TBL] [Abstract][Full Text] [Related]
12. Toll-Like Receptor 9 Plays a Pivotal Role in Angiotensin II-Induced Atherosclerosis.
Fukuda D; Nishimoto S; Aini K; Tanaka A; Nishiguchi T; Kim-Kaneyama JR; Lei XF; Masuda K; Naruto T; Tanaka K; Higashikuni Y; Hirata Y; Yagi S; Kusunose K; Yamada H; Soeki T; Imoto I; Akasaka T; Shimabukuro M; Sata M
J Am Heart Assoc; 2019 Apr; 8(7):e010860. PubMed ID: 30905257
[TBL] [Abstract][Full Text] [Related]
13. Hepcidin-ferroportin axis controls toll-like receptor 4 dependent macrophage inflammatory responses in human atherosclerotic plaques.
Habib A; Polavarapu R; Karmali V; Guo L; Van Dam R; Cheng Q; Akahori H; Saeed O; Nakano M; Pachura K; Hong CC; Shin E; Kolodgie F; Virmani R; Finn AV
Atherosclerosis; 2015 Aug; 241(2):692-700. PubMed ID: 26125411
[TBL] [Abstract][Full Text] [Related]
14. Fibronectin Containing Extra Domain A Induces Plaque Destabilization in the Innominate Artery of Aged Apolipoprotein E-Deficient Mice.
Doddapattar P; Jain M; Dhanesha N; Lentz SR; Chauhan AK
Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):500-508. PubMed ID: 29326316
[TBL] [Abstract][Full Text] [Related]
15. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice.
Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS
Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917
[TBL] [Abstract][Full Text] [Related]
16. Macrophage polarization by angiotensin II-type 1 receptor aggravates renal injury-acceleration of atherosclerosis.
Yamamoto S; Yancey PG; Zuo Y; Ma LJ; Kaseda R; Fogo AB; Ichikawa I; Linton MF; Fazio S; Kon V
Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2856-64. PubMed ID: 21979434
[TBL] [Abstract][Full Text] [Related]
17. An Exploratory Pilot Study of Genetic Marker for IgE-Mediated Allergic Diseases with Expressions of FcεR1α and Cε.
Liao EC; Chang CY; Hsieh CW; Yu SJ; Yin SC; Tsai JJ
Int J Mol Sci; 2015 Apr; 16(5):9504-19. PubMed ID: 25923080
[TBL] [Abstract][Full Text] [Related]
18. EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis.
Finney AC; Funk SD; Green JM; Yurdagul A; Rana MA; Pistorius R; Henry M; Yurochko A; Pattillo CB; Traylor JG; Chen J; Woolard MD; Kevil CG; Orr AW
Circulation; 2017 Aug; 136(6):566-582. PubMed ID: 28487392
[TBL] [Abstract][Full Text] [Related]
19. Pivotal role of serum- and glucocorticoid-inducible kinase 1 in vascular inflammation and atherogenesis.
Borst O; Schaub M; Walker B; Schmid E; Münzer P; Voelkl J; Alesutan I; Rodríguez JM; Vogel S; Schoenberger T; Metzger K; Rath D; Umbach A; Kuhl D; Müller II; Seizer P; Geisler T; Gawaz M; Lang F
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):547-57. PubMed ID: 25614279
[TBL] [Abstract][Full Text] [Related]
20. TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice.
Wu C; He S; Peng Y; Kushwaha KK; Lin J; Dong J; Wang B; Lin J; Shan S; Liu J; Huang K; Li D
J Mol Cell Cardiol; 2014 Nov; 76():33-45. PubMed ID: 25117469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
